HC Wainwright & Co. Maintains Buy on Ortho Clinical Diagnostic, Raises Price Target to $30
HC Wainwright & Co. analyst Yi Chen maintains Ortho Clinical Diagnostic (NASDAQ:OCDX) with a Buy and raises the price target from $27 to $30.
Ortho Clinical Diagnostic Q2 Adj. EPS $0.16 Beats $0.14 Estimate, Sales $492.50M Beat $475.86M Estimate
Ortho Clinical Diagnostic (NASDAQ:OCDX) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. The company reported quarterly sales of $492.50 million which
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Ortho Clinical Diagnostics’ COVID-19 Antibody Test Gets FDA Emergency Use Approval
The FDA has granted Emergency Use Authorization (EUA) to Ortho Clinical Diagnostics’ (NASDAQ:OCDX) VITROS Anti-SARS-CoV-2 IgG Quantitative Test. The company says it…
Ortho Clinical Diagnostics’ Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization
Ortho Clinical Diagnostics (NASDAQ:OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS® Anti-SARS-CoV-2 IgG Quantitative Test is the first
Ortho Clinical Diagnostics Announces Distribution Agreement With Thermo Fisher To Provide And Support MAS Quality Controls And LabLink xL Quality Assurance Software; Terms Not Disclosed
RARITAN, N.J., July 7, 2021 /CNW/ -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's largest pure-play, in-vitro diagnostics (IVD) companies, today announced its distributionRARITAN, N.J., July 7, 2021 /CNW/ --
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 14)
Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response
- Ortho is the only company that offers laboratories in the U.S. a quantitative test in combination with a nucleocapsid test
- Both new antibody tests help health care teams differentiate the cause of
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.